share_log

NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate

NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate

NRX Pharmicals第一季度每股收益美元(0.74美元)未達到預期(0.37美元)
Benzinga ·  05/14 16:37

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.37) by 100 percent. This is a 53.75 percent increase over losses of $(1.60) per share from the same period last year.

NRX Pharmicals(納斯達克股票代碼:NRXP)公佈的季度虧損爲每股0.74美元,比分析師普遍預期的0.37美元(0.37美元)低100%。這比去年同期每股虧損1.60美元(1.60美元)增長了53.75%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論